Mitsubishi UFJ Asset Management
DNA icon

Mitsubishi UFJ Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Buy
30,427
+441
+1% +$3.69K ﹤0.01% 959
2026
Q1 		$184K Sell
29,986
-741
-2% -$6.16K ﹤0.01% 991
2025
Q4 		$267K Buy
30,727
+1,122
+4% +$12.1K ﹤0.01% 973
2025
Q3 		$432K Buy
29,605
+59
+0.2% +$706 ﹤0.01% 891
2025
Q2 		$332K Buy
+29,546
New +$229K ﹤0.01% 911
2024
Q2 		– Sell
-3,840
Closed -$178K – 1579
2024
Q1 		$178K Sell
3,840
-176
-4% -$9.11K ﹤0.01% 971
2023
Q4 		$247K Sell
4,016
-1,610
-29% -$98.6K ﹤0.01% 988
2023
Q3 		$407K Buy
5,626
+497
+10% +$39.7K ﹤0.01% 944
2023
Q2 		$382K Buy
5,129
+2,038
+66% +$121K ﹤0.01% 964
2023
Q1 		$164K Buy
3,091
+222
+8% +$14.1K ﹤0.01% 1045
2022
Q4 		$181K Buy
2,869
+367
+15% +$33.8K ﹤0.01% 1030
2022
Q3 		$312K Buy
2,502
+54
+2% +$6.43K ﹤0.01% 970
2022
Q2 		$233K Buy
+2,448
New +$299K ﹤0.01% 1028

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Mitsubishi UFJ Asset Management's DNA Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Ginkgo Bioworks (DNA) stake by 1.5% in Q2 2026, buying an estimated $3.69K and bringing the position to 30,427 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Mitsubishi UFJ Asset Management first reported a position in DNA in Q2 2022 and has held it in 13 quarters since. The position peaked at $432K in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 30,427 shares of Ginkgo Bioworks worth $302K as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 441 Ginkgo Bioworks shares in Q2 2026, an estimated $3.69K.
  • Ginkgo Bioworks made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #959 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 13 quarters since.
  • Mitsubishi UFJ Asset Management's Ginkgo Bioworks position peaked at $432K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.